Dr. Bahareh Bahadini, MD

Dr. Bahadini practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Bahadini's NPI, 1295734614, was assigned on July 18, 2005. Dr. Bahadini graduated from Keck School of Medicine of USC in 1996. Dr. Bahadini's California license number on file is A64997.

Dr. Bahadini's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (626) 256-4673.

Dr. Bahadini's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Bahadini is also affiliated with Los Robles Regional Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Bahadini to 2 more hospitals, 1 group practice or clinic and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bahadini practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bahadini's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bahadini is board certified in medical oncology by the American Board of Internal Medicine. Dr. Bahadini has a license on file in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Bahadini treats.

CMS data shows 102,891 Medicare services from Dr. Bahadini across 41 procedure codes in 2024, for 391 Medicare patients. Medicare paid $1,735,836 for them. Every service was in an office.

CMS counts 391 Medicare patients who saw Dr. Bahadini in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bahadini's median patient age at 69, with 69% women.

In 2024, Dr. Bahadini wrote 486 Medicare Part D claims for 114 patients. 76% of them were for generic drugs. CMS names the drug for 293 of them, across 14 drugs with 11 or more claims each, at $613,474 in total drug cost. In 2023, CMS named 281 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bahadini for performance year 2024, reported as part of a group. Dr. Bahadini accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bahadini as offering telehealth.

Dmand AI links 4 papers to Dr. Bahadini, published from 2020 to 2023. Dr. Bahadini has published most often in J Clin Med. Dr. Bahadini's most frequent co-authors are Camille Adeimy, MD, Eugene R. Ahn, MD and Mihaela Carmen Cristea, MD.

Dmand AI links Dr. Bahadini to 3 clinical trials, 3 of them phase 3 studies. 2 are still active or recruiting.

CMS Open Payments shows 200 general payments to Dr. Bahadini from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Bristol-Myers Squibb Company paid the most, $663.

Dr. Bahadini graduated from Keck School of Medicine of USC in 1996.

Dr. Bahadini is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.